Situations where multiple strategies we follow start to overlap are not all that common but you run across them from time to time if you are paying close attention. One such situation was the acquisition of Biohaven (BHVN) by Pfizer (PFE) last year and the subsequent spinoff of the non-migraine pipeline of Biohaven into a separate company.
When reviewing the list of management transitions earlier this week, Light & Wonder (LNW) popped up as another one of those situations. The company: